Suppr超能文献

肝脏与类固醇激素——一点点p53会有影响吗?

Liver and Steroid Hormones-Can a Touch of p53 Make a Difference?

作者信息

Charni-Natan Meital, Aloni-Grinstein Ronit, Osher Etty, Rotter Varda

机构信息

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona, Israel.

出版信息

Front Endocrinol (Lausanne). 2019 Jun 12;10:374. doi: 10.3389/fendo.2019.00374. eCollection 2019.

Abstract

The liver is the main metabolic organ in the body, serving as a significant hormonal secretory gland and functioning to maintain hormone balance and homeostasis. Steroid hormones regulate various biological pathways, mainly in the reproductive system and in many metabolic processes. The liver, as well as steroid hormones, contribute significantly, through functional intertwine, to homeostasis maintenance, and proper responses during stress. Malfunction of either has a significant impact on the other and may lead to severe liver diseases as well as to several endocrine syndromes. Thus, the regulation on liver functions as on steroid hormones levels and activities is well-controlled. p53, the well-known tumor suppressor gene, was recently found to regulate metabolism and general homeostasis processes, particularly within the liver. Moreover, p53 was shown to be involved in steroid hormones regulation. In this review, we discuss the bi-directional regulation of the liver and the steroid hormones pointing to p53 as a novel regulator in this axis. A comprehensive understanding of the molecular mechanisms of this axis may help to prevent and treat related disease, especially with the increasing exposure of the population to environmental steroid hormones and steroid hormone-based medication.

摘要

肝脏是人体主要的代谢器官,也是一个重要的内分泌腺,其功能是维持激素平衡和体内稳态。类固醇激素主要在生殖系统和许多代谢过程中调节各种生物学途径。肝脏和类固醇激素通过功能上的相互交织,对维持体内稳态以及应激期间的适当反应起着重要作用。任何一方功能失调都会对另一方产生重大影响,可能导致严重的肝脏疾病以及多种内分泌综合征。因此,肝脏功能以及类固醇激素水平和活性的调节是受到良好控制的。著名的肿瘤抑制基因p53最近被发现可调节代谢和一般的体内稳态过程,特别是在肝脏内。此外,p53还被证明参与类固醇激素的调节。在本综述中,我们讨论肝脏和类固醇激素的双向调节,指出p53是该轴中的一个新调节因子。全面了解该轴的分子机制可能有助于预防和治疗相关疾病,特别是随着人群接触环境类固醇激素和基于类固醇激素的药物的增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e972/6581675/5e45d933c7f5/fendo-10-00374-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验